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access article under the CC BY-NC-NDSummary Background/Objective: The purpose of this study was to evaluate supraspinatus
tenocyte viability and metabolism in explants exposed to various local anaesthetics and corti-
costeroids. Our hypothesis was that the tendons exposed to these common injectates would
have significantly decreased cell viability and metabolism compared with controls.
Methods: Supraspinatus tendon explants were obtained from dogs, placed in a culture media,
and randomly assigned to one of the following groups: culture media only (control), 1% lido-
caine, 0.5% lidocaine, 0.25% bupivacaine, 0.125% bupivacaine, 0.0625% bupivacaine, beta-
methasone acetate (5 mg), methylprednisolone acetate (40 mg), or triamcinolone acetonide
(40 mg). Cell viability was determined on Days 1 and 7 after culture treatment using calcein
AM (live cell) and Sytox Blue (dead cell) stains. Tissue metabolism was assessed on Days 1
and 7 using the resazurin blue metabolic assay. Significant differences were evaluated using
a one-way analysis of variance with Tukey post hoc analysis.
Results: Compared with the controls, there were significant decreases in cell viability noted at
Days 1 and 7 in tenocytes exposed to 1% lidocaine, betamethasone, and methylprednisolone.
Significant decreases in cell metabolism were also noted at Days 1 and 7 in those groups. Treat-
ment with 0.125% bupivacaine, 0.0625% bupivacaine, and triamcinolone demonstrated no
decrease in cell viability or metabolism when compared with controls at any time point.
Conclusion: This data confirms that peritendinous injection of commonly used local anaes-
thetics and corticosteroids results in significant supraspinatus tenotoxicity in vitro. Further
in vivo studies are required before making definitive clinical recommendations.f Missouri, Missouri Orthopaedic Institute, 1100 Virginia Avenue, Columbia, MO 65212, USA.
issouri.edu (C.W. Nuelle).
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Local anaesthetic and corticosteroid injections have been
widely used as a treatment option for many musculoskel-
etal conditions. Intra-articular injections are often used to
treat arthritic joints whereas extra-articular or peri-
tendinous injections are often used to treat inflammatory
conditions [1e3]. Recent studies, however, have suggested
potential toxicity at the cellular level after routine use of
certain injection agents [4e7]. While the acute clinical
result is often relief of symptoms, the potential for toxicity
at the cellular level and associated long term morbidity has
not yet been fully elucidated.
Numerous studies have been conducted which have
demonstrated chondrotoxic properties of local anaesthetic
and corticosteroid agents [4e13]. Someof these studies have
shown that even a single exposure to anaesthetics or corti-
costeroids may result in loss of chondrocyte viability. These
studies have demonstrated damaging effects of anaesthetic
agents alone or in combination with corticosteroids. While
there have been many recent investigations documenting
chondrotoxicity of local anaesthetics and cortisone de-
rivatives, there have been less studies demonstrating similar
toxic effects on tenocytes and tendons [14e18]. Rotator cuff
pathology, in particular, is frequently treated clinically with
steroid injections, and the deleterious effects of various
steroid derivatives on rotator cuff tendons have been shown
in previous animal models [1,3,19,20]. Considering the cur-
rent usage frequency of steroid and combination steroid and
anaesthetic injections, it is valuable to further evaluate the
effects of multiple commonly used agents.
The purpose of this in vitro study was to evaluate the
toxicity of commonly used clinical doses of both local
anaesthetics and corticosteroids on tenocytes in a canine
supraspinatus tendon explant model. This explant model
preserves the extracellular matrix and cell heterogeneity of
the tissues in an effort to optimally mimic in vivo conditions.
Our hypothesis was that the tendons exposed to routinely
used local anaesthetics and corticosteroids at clinically
relevant concentrations would have significantly decreased
cell viability and metabolism compared with controls.Table 1 Amount of medication used for each treatment
subset.
Group Media (mL) Drug (mL)
Negative control 7
0.25% Bupivacaine 7 þ 5
0.125% Bupivacaine 7 þ 2.5
0.0625% Bupivacaine 7 þ 1.25
1.0% Lidocaine 7 þ 2
0.5% Lidocaine 7 þ 1
Betamethasone 5 mg 7 þ 1.25
Methylprednisolone (depo) 40mg 7 þ 1
Triamcinolone (kenalog) 40mg 7 þ 1Methods
Tissue culture and harvest
All procedures were approved under the Institutional Ani-
mal Care and Use Committee policies and procedures for
the use of canine cadaveric tissues. Seven adult (ageZ 2e4
years and mean weight Z 28.6 kg), purpose-bred, intact
female mongrel canine cadavers were obtained immedi-
ately after euthanasia that was performed for reasons un-
related to this study. All shoulder joints used were free ofintra- and extra-articular pathology based on complete
gross examination. Supraspinatus tendon samples were
harvested from the shoulder under sterile conditions. Tis-
sue explants, 4-mm thick, were prepared using a dermal
biopsy punch (Fray Products, Buffalo, NY, USA) and were
sliced in half to observe the viability of tenocytes across the
thickness of the specimen.
The tendon tissue explants were cultured in 24-well
plates (Becton Dickinson Labware, Franklin Lakes, NJ,
USA) in media containing Dulbecco’s modified Eagle’s me-
dium with high glucose (Gibco, Invitrogen, Carlsbad, CA,
USA) supplemented with 1% insulinetransferrineselenium,
penicillin, streptomycin, amphotericin B, L-ascorbic acid,
L-glutamine, and nonessential amino acids. Explants (nZ 7/
group) were cultured for 24 hours prior to assignment to one
of the following treatment groups: 1% lidocaine, 0.5% lido-
caine, 0.25% bupivacaine, 0.125% bupivacaine, 0.0625%
bupivacaine, betamethasone acetate (5 mg), methylpred-
nisolone acetate (40 mg), and triamcinolone (40 mg). The
concentration for each treatment group, shown in Table 1,
was based on the average volume of injectate used for
treatment of equivalent human pathology and the volume of
drug required to obtain the desired concentration for
explant culture [21]. Explants were cultured in 1 mL of
treatment or control media and incubated at 37 C with 5%
CO2 at 95% humidity for either 24 hours or 7 days.Cell viability
Cell viability in tendon explants was assessed after 1 day
and 7 days of culture by fluorescent microscopy using the
fluorescent stains calcein AM (excitation Z 495 nm;
emission Z 515 nm) to stain live cells and Sytox Blue
(excitationZ 633 nm, 635 nm; emissionZ 658 nm) to stain
nonviable cells (Life Technologies, Carlsbad, CA, USA). At
the time of tissue collection on each day, the explants were
incubated in the stain for 30 minutes at room temperature.
Tissue images were recorded at 4 magnification using an
Figure 1 Tenocyte cell viability scores (viable cells/mm2).
Mean viable cell density on Days 1 and 7. 0.25 BZ 0.25% bupi-
vacaine; 0.125 B Z 0.125% bupivacaine; 0.0625 B Z 0.0625%
bupivacaine; 1 L Z 1% lidocaine; 0.5 L Z 0.5% lidocaine;
Beta Z betamethasone; Methyl Z methylprednisolone;
NEGZ negative control; TriamZ triamcinolone. * Significantly
lower viable cell density compared with the negative control.
Figure 2 Level of tenocyte metabolic activity using the Ala-
mar Blue metabolic assay. Mean media fluorescence level on
Days 1 and 7 of culture post-treatment. 0.25 B Z 0.25% bupi-
vacaine; 0.125 B Z 0.125% bupivacaine; 0.0625 B Z 0.0625%
bupivacaine; 1 L Z 1% lidocaine; 0.5 L Z 0.5% lidocaine;
Beta Z betamethasone; Methyl Z methylprednisolone;
NEGZ negative control; TriamZ triamcinolone. * Significantly
lower viable cell density compared with the negative control.
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software (Olympus, Tokyo, Japan). Subjective assessment
of viability was performed by six investigators blinded to
the treatment and averaged to ensure consistent overall
assessment. Each tendon tissue explant was given a score
from 0 (0% viability) to 5 (100% viability). The scores from
all investigators were averaged to obtain a mean tenocyte
subjective viability score for each explant.
Cell metabolic activity assay
The metabolic activity of tendon explants was assessed
using the Alamar Blue assay (SigmaeAldrich, St. Louis, MO,
USA); this is a fluorescent metabolic assay used for Days 1
and 7 of culture. Resazurin is converted to a fluorescent
compound, resorufin, by metabolically active cells. The
degree of fluorescence detected in the media provides a
quantitative measure of the number of viable cells in a
tissue. Resazurin (100 mL) was added to the media of each
explant and incubated overnight at 37 C. A 200-mL sample
of the media was transferred to a black 96-well plate,
and the level of fluorescence in the media was measured
(excitationZ 530 nm; emission Z 590 nm) using a Synergy
HT plate reader (BioTek, Winooksi, VT, USA).
Statistical analysis
Statistical analysis was performed using SigmaPlot v12.0
(Systat Software Inc., San Jose, CA, USA). A one-way
analysis of variance (ANOVA) using Tukey post hoc com-
parisons was used for the detection of statistically signifi-
cant differences between the control and treatment
groups, with significance set at p < 0.05.
Results
Cell viability
Viability scores for tendon explants cultured for 1 day
with 1.0% lidocaine, 0.25% bupivacaine, betamethasone, and
methylprednisolone were significantly lower (p 0.001) than
those for controls. Viability scores of tendonexplants cultured
for 1 day with 0.5% lidocaine, 0.125% bupivacaine, 0.0625%
bupivacaine, and triamcinolone were not significantly
different from those of controls (pZ 0.12e0.78). On Day 7 of
culture, viability scores for tendons cultured with 1.0% lido-
caine, betamethasone, and methylprednisolone remained
significantly lower (p  0.001) than those for controls. While
the viability scores for tendons cultured with 0.25% bupiva-
caine remained numerically lower than those for controls
on Day 7, this difference was not statistically significant
(pZ 0.24). Furthermore, viability scores for tendon explants
cultured for 7 days with 0.5% lidocaine, 0.125% bupivacaine,
0.0625% bupivacaine, and triamcinolone were not signifi-
cantly lower than those forcontrols (pZ0.12e0.78;Figure1).
Cell metabolic activity assay
On Day 1 of culture, the level of metabolic activity,
measured by the level of fluorescence in the media oftendon explants cultured with 1% lidocaine, 0.5% lidocaine,
0.25% bupivacaine, betamethasone, and methylpredniso-
lone, was significantly lower (p  0.001e0.003) than that
for controls. There was no significant difference in the level
of tissue metabolic activity between tendon explants
cultured with 0.125% bupivacaine, 0.0625% bupivacaine, or
triamcinolone (p Z 0.26e0.31) and controls on Day 1
(Figure 2). On Day 7 of culture, the level of metabolic
activity of tendon explants cultured with 1% lidocaine,
betamethasone, and methylprednisolone remained signifi-
cantly lower (p  0.001) than that for controls. However, in
agreement with the viability scores, the level of metabolic
activity of tendon explants cultured with 0.5% lidocaine
and 0.25% bupivacaine was not significantly different
(p Z 0.1) than that for controls on Day 7. Furthermore,
there was still no significant difference in the level of
metabolic activity between tendon explants cultured with
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(p Z 0.07e0.47) and controls on Day 7 (Figure 2).Discussion
The purpose of this in vitro study was to evaluate the
toxicity of commonly used clinical doses of both local
anaesthetics and corticosteroids on tenocytes in a canine
supraspinatus tendon explant model. The present study
demonstrated that 1% lidocaine, betamethasone, and
methylprednisolone had significantly negative effects on
cell viability and metabolism at both the time points
tested. In contrast, 0.125% and 0.0625% bupivacaine and
triamcinolone did not differ significantly from controls with
respect to cell viability or cell metabolism at either time
point. The remaining agents (0.5% lidocaine and 0.25%
bupivacaine) showed mixed results.
The toxic effects of local anaesthetics and corticoste-
roids have been documented by a number of studies in
recent years [4e11]. The negative effects of these agents
have been reported to occur in intra- and extra-articular
tissues, with chondrocytes being most frequently studied.
While the chondrotoxic effects of anaesthetics and cor-
ticosteroids have been well documented, there have been
fewer studies demonstrating their effects on soft tissues,
particularly tendons. Piper et al [14] demonstrated varying
levels of toxicity of lidocaine, ropivacaine, and dexameth-
asone on bovine tenocytes in culture. In their study, lido-
caine was noted to have increasingly negative effects on
tenocyte viability as the concentration increased. Ropiva-
caine alone was not found to have significantly negative
toxic effects; however, when both the anaesthetics were
combined with dexamethasone, they were noted to have
significantly increased toxicity to tenocytes. In a separate
study, Sherb et al [16] demonstrated a decrease in the
cultured tenocyte cell proliferation and extracellular matrix
component production after exposure to bupivacaine
alone. Yang et al [22] performed an in vitro study evaluating
the effects of a combination of 1% lidocaine with triam-
cinolone on rat patellar tendon-derived tenocytes. They
noted significantly decreased cell viability and a markedly
decreased expression of tenocyte-related genes in the
tenocytes treated with the medication combination versus
controls. They concluded that a combination injection of 1%
lidocaine with triamcinolone should be used with caution in
the treatment of tendon disorders [22].
Sung et al [23] recently studied cytotoxic effects of
ropivacaine, bupivacaine, and lidocaine on cultured human
rotator cuff tenofibroblasts. They studied six anaesthetic
subgroups (two different concentrations for each agent)
and exposed the tenofibroblasts to each of these agents
over increasing duration. They used 0.2% and 0.75% ropi-
vacaine, 0.25% and 0.5% bupivacaine, and 1% and 2% lido-
caine. They noted significantly decreased cell viability with
increased anaesthetic concentrations and exposure times.
They also noted increases in cellular factors that could
promote cell death, such as increased production of intra-
cellular reaction oxygen species and increased activation of
mitogen-activated protein kinases and caspase-3/7. Of the
subgroups studied, the lowest concentration of ropivacaine
(0.2%) was noted to be the least toxic. They concluded thatthe greatest margin of safety for the anaesthetics studied
was found in the lowest concentrations and as such higher
concentrations should be used with caution.
Scutt et al [15] and Wong et al [17] independently
studied the effects of dexamethasone exposure on teno-
cytes. Scutt et al [15] injected variable levels of dexa-
methasone around rat tail tendons and noted decreases in
tenocyte proliferation and collagen synthesis as dexa-
methasone concentrations increased. Wong et al [17]
studied the response of human hamstring tendons to two
dexamethasone concentrations (10mM and 100mM) and
noted decreases in cell viability of 35% and 45%, respec-
tively. The conclusions of each of these studies were that
dexamethasone could have potentially negative effects on
tenocyte cell proliferation and viability.
Beitzel et al [24] conducted an in vitro study to evaluate
the effects ofmethylprednisolone, ketorolac tromethamine,
and platelet-rich plasma (PRP), alone and in combinations,
on human chondrocytes and tenocytes isolated from the
samples of biceps tendon. They noted significantly increased
tenocyte cell viability with PRP treatment and combined PRP
and ketorolac tromethamine treatment compared with
controls. Cell viability was significantly decreased after
exposure to methylprednisolone and methylprednisolone
combined with PRP compared with controls, with the addi-
tion of PRP slightly mitigating the decrease in viability. They
concluded that tenocyte exposure to methylprednisolone
decreases cell viability, with the addition of PRP only
partially reversing the negative effect [24].
Similar to the studies by Piper et al [13], Yang et al [22],
and Sung et al [23],we noted significantly deleterious effects
of 1% lidocaine. However, we noted that 0.5% lidocaine had a
less deleterious effect on cell viability than 1% lidocaine. This
is in agreement with data from Piper et al who noted that
increasing concentrations of lidocaine had increasingly
negative effects on cell viability. Similar to Sherb et al [16]
and Sung et al [23], we also noted negative effects of a
higher concentration (but common clinical dose) of bupiva-
caine (0.25%). In contrast to their studies, however, we also
studied lower concentrations (0.125% and 0.0625%) of bupi-
vacaine and found that the tenocyte exposure to these lower
concentrations did not differ significantly from controls. This
data is clinically relevant as it indicates that using lower
concentrations of these injectateswould be better tolerated
long term. Our results are also in accordance with those of
previous studies in regards to the influence of corticoste-
roids. We noted significantly negative effects of betame-
thasone and methylprednisolone, which was also noted by
Piper et al, Farkas et al [11], and Beitzel et al [24]. In contrast
to the study performed by Yang et al [22], however, we did
not note significantly negative effects of triamcinolone on
tenocyte viability or metabolism. This difference was partly
because they studied the effects of a combination exposure
of triamcinolone with 1% lidocaine, whereas we studied the
effects of each agent individually.Study limitations
This is an in vitro model using canine tendon explants
and thus cannot be broadly extrapolated to all settings.
Another limitation is that this study examined the effects of
24 C.W. Nuelle et al.individual anaesthetics and corticosteroids, not the com-
bination of agents, which are most commonly used clini-
cally. Our rationale for testing individual agents was to
detect a baseline effect of each individual agent indepen-
dently. This would further allow us to formulate potentially
stronger hypotheses on the effects of various combinations
of these agents in subsequent in vivo studies. By using
canine tendon explants, we were able to examine a wide
spectrum of agents in a valid translational model with
sufficient numbers to allow for delineation of the individual
effects of each independent agent. While a tendon explant
model preserves tissue architecture, extracellular matrix,
and cell phenotype, placing the tendon in culture alters its
environment and removes biomechanical forces with po-
tential resultant effects on cell viability, physiology, and
metabolism. While this limits the direct application of the
data to clinical implementation, the results are valid for
comparison across treatments as all explants were treated
in the same manner, and controls consistently showed
maintenance of cell viability, and phenotype and tissue
architecture throughout the explant. This experimental
design allowed us to provide unique data while adhering to
the ethical use of animals and the universal mandate to
“reduce, refine, and replace” with respect to animal
research. As such, these data provided important ex vivo
data to justify and guide the design of subsequent in vivo
research.
Conclusion
The results of this study contribute novel data to the
growing body of evidence suggesting that peritendinous
injection of commonly used local anaesthetics and corti-
costeroids results in significant supraspinatus tenotoxicity
in vitro. Further in vivo studies are required before defin-
itive clinical recommendations may be made.
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